Data Collective (DCVC)

Matt Ocko and Zachary Bogue co-founded DCVC and serve as co-managing partners. Ocko, a Yale physics graduate and named inventor on more than 50 granted or pending patents spanning systems virtualization, fraud detection and augmented reality, invested in Zoom, Fortinet, D-Wave, Uber, AngelList and Facebook before the firm. Bogue, a Harvard undergraduate and Georgetown-trained attorney with two decades in Silicon Valley as an entrepreneur, lawyer and angel investor, concentrates on computational drug discovery, nuclear energy, synthetic biology and applied AI for climate. The partnership has deepened through promotion from within. Rachel Slaybaugh joined from UC Berkeley, where she held tenure as an associate professor of nuclear engineering and directed Lawrence Berkeley National Laboratory's Cyclotron Road accelerator for entrepreneurial scientists. Ali Tamaseb, a biomedical engineer trained at Imperial College London, hardware operator and author of Super Founders, moved up to general partner.

DCVC has raised 13 funds and manages roughly $4 billion, built out from the seed-stage practice Matt Ocko and Zachary Bogue formalized as Data Collective in 2011. The platform now splits across flagship deep tech funds, opportunity vehicles that concentrate capital into breakout positions, and DCVC Bio, launched in 2018 with John Hamer and Kiersten Stead to invest specifically in computational biology and life sciences. In July 2023 the firm announced it had raised more than $1 billion in fresh capital and paired the announcement with its inaugural Deep Tech Opportunities report, which it has published annually since, most recently in 2026. Individual fund sizes are not disclosed. DCVC frames the whole platform as a single strategy rather than a set of sector sleeves: computational approaches applied to physical-world problems including fusion energy, satellite imaging and Earth observation, industrial biology, advanced manufacturing and drug discovery.